» Articles » PMID: 23161827

Bioreactors in Tissue Engineering - Principles, Applications and Commercial Constraints

Overview
Journal Biotechnol J
Specialty Biotechnology
Date 2012 Nov 20
PMID 23161827
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Bioreactor technology is vital for tissue engineering. Usually, bioreactors are used to provide a tissue-specific physiological in vitro environment during tissue maturation. In addition to this most obvious application, bioreactors have the potential to improve the efficiency of the overall tissue-engineering concept. To date, a variety of bioreactor systems for tissue-specific applications have been developed. Of these, some systems are already commercially available. With bioreactor technology, various functional tissues of different types were generated and cultured in vitro. Nevertheless, these efforts and achievements alone have not yet led to many clinically successful tissue-engineered implants. We review possible applications for bioreactor systems within a tissue-engineering process and present basic principles and requirements for bioreactor development. Moreover, the use of bioreactor systems for the expansion of clinically relevant cell types is addressed. In contrast to cell expansion, for the generation of functional three-dimensional tissue equivalents, additional physical cues must be provided. Therefore, bioreactors for musculoskeletal tissue engineering are discussed. Finally, bioreactor technology is reviewed in the context of commercial constraints.

Citing Articles

ColMA-based bioprinted 3D scaffold allowed to study tenogenic events in human tendon stem cells.

Cortella G, Lamparelli E, Ciardulli M, Lovecchio J, Giordano E, Maffulli N Bioeng Transl Med. 2025; 10(1):e10723.

PMID: 39801753 PMC: 11711214. DOI: 10.1002/btm2.10723.


Engineering interfacial tissues: The myotendinous junction.

Snow F, OConnell C, Yang P, Kita M, Pirogova E, Williams R APL Bioeng. 2024; 8(2):021505.

PMID: 38841690 PMC: 11151436. DOI: 10.1063/5.0189221.


Perfusable Tissue Bioprinted into a 3D-Printed Tailored Bioreactor System.

Gensler M, Malkmus C, Ockermann P, Mollmann M, Hahn L, Salehi S Bioengineering (Basel). 2024; 11(1).

PMID: 38247945 PMC: 10813239. DOI: 10.3390/bioengineering11010068.


Translation of biophysical environment in bone into dynamic cell culture under flow for bone tissue engineering.

Yamada S, Ockermann P, Schwarz T, Mustafa K, Hansmann J Comput Struct Biotechnol J. 2023; 21:4395-4407.

PMID: 37711188 PMC: 10498129. DOI: 10.1016/j.csbj.2023.08.008.


Towards the Standardization of Mesenchymal Stem Cell Secretome-Derived Product Manufacturing for Tissue Regeneration.

Chouaib B, Haack-Sorensen M, Chaubron F, Cuisinier F, Collart-Dutilleul P Int J Mol Sci. 2023; 24(16).

PMID: 37628774 PMC: 10454619. DOI: 10.3390/ijms241612594.